Efficacy of a Physical Rehabilitation Program Using Virtual Reality in Patients With Chronic Tendinopathy (Virtendon-Rehab)
VirtendonRehab
2 other identifiers
interventional
120
1 country
1
Brief Summary
Chronic tendinopathies (CT) have a high prevalence (30% of musculoskeletal injuries), causing pain, decreased physical activity and functionality, as well as limitations in daily life. Virtual reality (VR) fosters patient recovery through playful activities that promote competitiveness, stimulates motivation and continuous attention, allows individualizing the exercise program, objectively assessing the execution of the treatment and monitoring the patient's evolution. Therefore, the VIRTENDON-REHAB project aims to conduct a low-risk randomized controlled clinical trial to analyze the efficacy of a VR-based physical rehabilitation program in a population diagnosed with CT on pain, functionality, range of motion, strength, muscle activation pattern, kinesiophobia, quality of life, adherence to treatment and patient satisfaction with the use of the system, compared to a control group. Likewise, the aim is to characterize the clinical profile of this population and to know the relationships between the previous variables. Measurements will be taken at the beginning of the intervention, at the end (12 weeks) and 3 months after the end of the intervention. A descriptive analysis will be performed, inter- and intra-group differences will be analyzed by means of t-Student, Wilcoxon, Mann-Whitney U and mixed ANOVA tests. Cohen's d will be used to determine the effect size. Relationships between variables will be analyzed using structural equations. The results obtained will allow improving knowledge on the management of CT using VR, as well as improving clinical care and reducing healthcare costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2023
CompletedFirst Posted
Study publicly available on registry
September 28, 2023
CompletedStudy Start
First participant enrolled
November 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedMay 10, 2024
September 1, 2023
11 months
September 11, 2023
May 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Disability (Shoulder And Pain Disability Index)
Longitudinal change from 0 to 100. Higher scores mean worse outcome.
Fom Baseline up to 24 Weeks Follow-up
Disability (Victorian Institute of Sport Assessment - Patellar)
Longitudinal change from 0 to 100. Higher scores mean better outcome.
Fom Baseline up to 24 Weeks Follow-up
Disability (Victorian Institute of Sport Assessment - Achilles)
Longitudinal change from 0 to 100. Higher scores mean better outcome.
Fom Baseline up to 24 Weeks Follow-up
Pain (Visual Analogue Scale)
Longitudinal change from 0 to 10. Higher scores mean worse outcome.
Fom Baseline up to 24 Weeks Follow-up
Secondary Outcomes (6)
Range of motion (Goniometer)
Fom Baseline up to 24 Weeks Follow-up
Strength (Dynamometer)
Fom Baseline up to 24 Weeks Follow-up
Kinesiophobia (Tampa Scale Questionnaire)
From Baseline up to 24 Weeks Follow-up
Quality of Life (36-item Short Form Survey)
From Baseline up to 24 Weeks Follow-up
Adherence (Exercise Adherence Rating Scale)
12 Weeks and 24 Weeks
- +1 more secondary outcomes
Study Arms (2)
VR group
EXPERIMENTALThe VR intervention program for the experimental group will be carried through the Oculus Quest 2 device (which consists of VR glasses and different accessories) will be used, in conjunction with software specifically designed for physical rehabilitation of upper and lower limbs: Dynamics VR. This VR intervention will be performed in addition to the patient's usual treatment program.
Control group
OTHERInterventions
The VR intervention program for the experimental group will be carried out with a frequency of 3 sessions/week, duration of approximately 45 minutes, and for a total of 12 weeks, being performed in addition to the patient's usual treatment program. The Oculus Quest 2 device (which consists of VR glasses and different accessories) will be used, in conjunction with software specifically designed for physical rehabilitation of upper and lower limbs: Dynamics VR. Specifically, the specific functional rehabilitation program will be used, which comprises exercises that are easy to perform, with a playful component, and which encourage the patient's continuous attention to the task performed, acting as a distractor phenomenon in the face of restrictive movement factors such as fear of pain or movement. This software offers the possibility of adjusting the number of repetitions and characteristics of the exercises, thus allowing an individualized physical rehabilitation
The control group will only receive their usual treatment program for the 12-week duration of the study.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of tendinopathy (shoulder rotator cuff tendinopathy, epicondylitis/epicondylitis, patellar tendinopathy, achilles tendinopathy).
- Duration of symptoms: greater than 6 weeks.
You may not qualify if:
- People who have any pathology that prevents them from performing physical exercise.
- Persons who have undergone surgery.
- Persons who have an illness that may be a contraindication to the proposed procedure.
- Persons who have received exercise therapy in the last 3 months.
- Persons who have received corticosteroid injections in the last 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Nursing and Physiotherapy
Cadiz, 11009, Spain
Related Publications (7)
Kaux JF, Forthomme B, Goff CL, Crielaard JM, Croisier JL. Current opinions on tendinopathy. J Sports Sci Med. 2011 Jun 1;10(2):238-53.
PMID: 24149868BACKGROUNDMallows A, Debenham J, Walker T, Littlewood C. Association of psychological variables and outcome in tendinopathy: a systematic review. Br J Sports Med. 2017 May;51(9):743-748. doi: 10.1136/bjsports-2016-096154. Epub 2016 Nov 16.
PMID: 27852585BACKGROUNDChen KB, Sesto ME, Ponto K, Leonard J, Mason A, Vanderheiden G, Williams J, Radwin RG. Use of Virtual Reality Feedback for Patients with Chronic Neck Pain and Kinesiophobia. IEEE Trans Neural Syst Rehabil Eng. 2017 Aug;25(8):1240-1248. doi: 10.1109/TNSRE.2016.2621886. Epub 2016 Oct 26.
PMID: 27810828BACKGROUNDDominguez-Tellez P, Moral-Munoz JA, Salazar A, Casado-Fernandez E, Lucena-Anton D. Game-Based Virtual Reality Interventions to Improve Upper Limb Motor Function and Quality of Life After Stroke: Systematic Review and Meta-analysis. Games Health J. 2020 Feb;9(1):1-10. doi: 10.1089/g4h.2019.0043.
PMID: 32027185BACKGROUNDAlmekinders LC, Almekinders SV. Outcome in the treatment of chronic overuse sports injuries: a retrospective study. J Orthop Sports Phys Ther. 1994 Mar;19(3):157-61. doi: 10.2519/jospt.1994.19.3.157.
PMID: 8156067BACKGROUNDCook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009 Jun;43(6):409-16. doi: 10.1136/bjsm.2008.051193. Epub 2008 Sep 23.
PMID: 18812414BACKGROUNDLucena-Anton D, Dominguez-Romero JG, Chacon-Barba JC, Santi-Cano MJ, Luque-Moreno C, Moral-Munoz JA. Efficacy of a physical rehabilitation program using virtual reality in patients with chronic tendinopathy: A randomized controlled trial protocol (VirTendon-Rehab). Digit Health. 2025 Feb 18;11:20552076241297043. doi: 10.1177/20552076241297043. eCollection 2025 Jan-Dec.
PMID: 39974760DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- A single-blind method will be carried out on the persons collecting and analysing the data
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2023
First Posted
September 28, 2023
Study Start
November 28, 2023
Primary Completion
November 1, 2024
Study Completion
December 1, 2024
Last Updated
May 10, 2024
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share